Intraoperative platelet rich plasma usage in total knee arthroplasty: does it help?
Thomas B Pace, Jonathan L Foret, M Jason Palmer, Stephanie L Tanner, Rebecca G Snider, Thomas B Pace, Jonathan L Foret, M Jason Palmer, Stephanie L Tanner, Rebecca G Snider
Abstract
Autologous platelet rich plasma preparations, commonly referred to as platelet gel, have been reported to have benefits when used in total knee replacement of less blood loss and better motion, with few reported complications. This retrospective review of 268 consecutive primary total knee arthroplasty cases compares postsurgical range of motion at 2, 8, and 12 weeks, knee manipulation rates, change in hemoglobin, and complications between one group receiving a platelet gel preparation (135 cases), and an equivalent group receiving no platelet gel preparation (133 control cases). No difference was found between groups in manipulation rates, knee range of motion, or changes in hemoglobin (P > 0.05). The use of platelet gel in this study did not have a significant effect on hemoglobin at 72 hours postoperatively, knee range of motion, or manipulation rates up to 3 months post-op in this patient cohort.
References
- Gardner MJ, Demetrakopoulos D, Klepchick PR, Mooar PA. The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty: an analysis of the haemoglobin, narcotic requirement and range of motion. International Orthopaedics. 2007;31(3):309–313.
- Everts PAM, Devilee RJJ, Oosterbos CJM, et al. Autologous platelet gel and fibrin sealant enhance the efficacy of total knee arthroplasty: improved range of motion, decreased length of stay and a reduced incidence of arthrofibrosis. Knee Surgery, Sports Traumatology, Arthroscopy. 2007;15(7):888–894.
- Berghoff WJ, Pietrzak WS, Rhodes RD. Platelet-rich plasma application during closure following total knee arthroplasty. Orthopedics. 2006;29(7):590–598.
- Creaney L, Hamilton B. Growth factor delivery methods in the management of sports injuries: the state of play. British Journal of Sports Medicine. 2008;42(5):314–320.
- Vives MJ, Hozack WJ, Sharkey PF, Moriarty L, Sokoloff B, Rothman RH. Fixed minidose versus-adjusted low-dose warfarin after total joint arthroplasty: a randomized prospective study. Journal of Arthroplasty. 2001;16(8):1030–1037.
- Lieberman JR, Wollaeger J, Dorey F, et al. The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty. Journal of Bone and Joint Surgery. American. 1997;79(3):319–325.
- Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of The Knee Society clinical rating system. Clinical Orthopaedics and Related Research. 1989;(248):13–14.
- Henderson JL, Keefe MA, Cupp CL, et al. The effects of autologous platelet gel on wound healing. Ear, Nose & Throat Journal. 2003;82(8):598–602.
- Burkus JK. Surgical treatment of the painful motion segment: matching technology with indications. Spine. 2005;30(16):S7–S15.
- Chiang C-C, Su C-Y, Huang C-K, Chen W-M, Chen T-H, Tzeng Y-H. Early experience and results of bone graft enriched with autologous platelet gel for recalcitrant nonunions of lower extremity. The Journal of Trauma. 2007;63(3):655–661.
- Yeaman MR. The role of platelets in antimicrobial host defense. Clinical Infectious Diseases. 1997;25(5):951–970.
- Krijgsveld J, Zaat SAJ, Meeldijk J, et al. Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. Journal of Biological Chemistry. 2000;275(27):20374–20381.
- Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Król W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study. Journal of Bone and Joint Surgery. British. 2007;89(3):417–420.
Source: PubMed